PhaseRx (PZRXQ) Price & Analysis

24 Followers

PZRXQ Stock Chart & Stats

$0.04

$0.00(0.00%)

At close: Dec 10 4:00 PM EST

$0.04

$0.00(0.00%)

Day’s Range― - ―

52-Week Range$0.00 - $0.09

Previous CloseN/A

Volume12.80K

Average Volume (3M)0.00

Market Cap

$12.00

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta24.95

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding11,690,000

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

PZRXQ FAQ

What was PhaseRx Inc’s price range in the past 12 months?

PhaseRx Inc lowest stock price was $0.00 and its highest was $0.09 in the past 12 months.

What is PhaseRx Inc’s market cap?

PhaseRx Inc’s market cap is $12.00.

When is PhaseRx Inc’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were PhaseRx Inc’s earnings last quarter?

Currently, no data Available

Is PhaseRx Inc overvalued?

According to Wall Street analysts PhaseRx Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does PhaseRx Inc pay dividends?

PhaseRx Inc does not currently pay dividends.

What is PhaseRx Inc’s EPS estimate?

PhaseRx Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does PhaseRx Inc have?

PhaseRx Inc has 11,690,000 shares outstanding.

What happened to PhaseRx Inc’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of PhaseRx Inc?

Currently, no hedge funds are holding shares in PZRXQ

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

PhaseRx Inc

PhaseRx, Inc. is a biopharmaceutical company dedicated to developing treatments for inherited enzyme deficiencies affecting the liver. Its therapeutic strategy involves intracellular enzyme replacement, powered by its unique Hybrid mRNA technology platform, which facilitates the production of absent enzymes directly within the body's cells. The company's pipeline includes several programs targeting urea cycle disorders, such as PRX-OTC for ornithine transcarbamylase deficiency, PRX-ASL for argininosuccinate lyase deficiency, and PRX-ASS1 for argininosuccinate synthetase deficiency. Established in 2006, PhaseRx is headquartered in Seattle, Washington.